Cannabinoid Modulation of Fear Extinction Brain Circuits: A Novel Target to Advance Anxiety Treatment

E-ISSN： 1873-4286|20|13|2212-2217

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.13, 2014-04, pp. : 2212-2217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

By Vinod K Yaragudri Hungund Basalingappa L

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite

The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats

By Pamplona Fabrício Prediger Rui Pandolfo Pablo Takahashi Reinaldo

Psychopharmacology, Vol. 188, Iss. 4, 2006-11 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

By Grigoriadis Dimitri E

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 651-684

Informa Healthcare

Access to resources Recommend Favorite

The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 842-862

Bentham Science Publishers

Access to resources Recommend Favorite